CN1662645B - 神经细胞的制备方法 - Google Patents

神经细胞的制备方法 Download PDF

Info

Publication number
CN1662645B
CN1662645B CN038149354A CN03814935A CN1662645B CN 1662645 B CN1662645 B CN 1662645B CN 038149354 A CN038149354 A CN 038149354A CN 03814935 A CN03814935 A CN 03814935A CN 1662645 B CN1662645 B CN 1662645B
Authority
CN
China
Prior art keywords
cell
stem cell
scs
neurocyte
neural
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN038149354A
Other languages
English (en)
Chinese (zh)
Other versions
CN1662645A (zh
Inventor
中山孝
井上顺雄
近藤靖
铃木丰
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tanabe Pharma Corp
Original Assignee
Mitsubishi Tanabe Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Tanabe Pharma Corp filed Critical Mitsubishi Tanabe Pharma Corp
Publication of CN1662645A publication Critical patent/CN1662645A/zh
Application granted granted Critical
Publication of CN1662645B publication Critical patent/CN1662645B/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • C12N5/0619—Neurons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • C12N5/0623—Stem cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/44—Thiols, e.g. mercaptoethanol
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/06—Anti-neoplasic drugs, anti-retroviral drugs, e.g. azacytidine, cyclophosphamide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]
    • C12N2501/235—Leukemia inhibitory factor [LIF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/13—Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/02—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Developmental Biology & Embryology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Ophthalmology & Optometry (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
CN038149354A 2002-06-24 2003-06-23 神经细胞的制备方法 Expired - Fee Related CN1662645B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP182386/2002 2002-06-24
JP2002182386 2002-06-24
PCT/JP2003/007906 WO2004007700A1 (ja) 2002-06-24 2003-06-23 神経系細胞の製造方法

Publications (2)

Publication Number Publication Date
CN1662645A CN1662645A (zh) 2005-08-31
CN1662645B true CN1662645B (zh) 2013-06-12

Family

ID=30112242

Family Applications (1)

Application Number Title Priority Date Filing Date
CN038149354A Expired - Fee Related CN1662645B (zh) 2002-06-24 2003-06-23 神经细胞的制备方法

Country Status (10)

Country Link
US (1) US8492145B2 (https=)
EP (1) EP1516926A4 (https=)
JP (1) JP4439396B2 (https=)
KR (1) KR100846643B1 (https=)
CN (1) CN1662645B (https=)
AU (1) AU2003246176B2 (https=)
CA (1) CA2489206C (https=)
IL (2) IL165772A0 (https=)
TW (1) TW200411058A (https=)
WO (1) WO2004007700A1 (https=)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060183221A1 (en) * 2003-03-31 2006-08-17 Schulz Thomas C Method for neural differentiation of embryonic stem cells using protease passaging techniques
WO2004099395A2 (en) * 2003-05-08 2004-11-18 Cellartis Ab A method for the generation of neural progenitor cells
US7820439B2 (en) * 2003-09-03 2010-10-26 Reliance Life Sciences Pvt Ltd. In vitro generation of GABAergic neurons from pluripotent stem cells
JP4481706B2 (ja) * 2004-03-31 2010-06-16 独立行政法人科学技術振興機構 脳梗塞疾患モデルマウス
TW200617165A (en) * 2004-09-06 2006-06-01 Tanabe Seiyaku Co Process for preparing a conditioned medium of astrocyte-like cells
US7803364B2 (en) 2005-11-17 2010-09-28 The Cleveland Clinic Foundation Multipotent neural stem cells
JP5279491B2 (ja) * 2006-05-19 2013-09-04 愛知県 脳損傷改善剤
DE102006060247A1 (de) * 2006-09-15 2008-03-27 Ossacur Ag Differenzierung von Stammzellen
WO2008066630A2 (en) * 2006-10-27 2008-06-05 Caritas St. Elizabeth Medical Center Of Boston, Inc. Methods for reprogramming adult somatic cells and uses thereof
US8338176B2 (en) * 2007-07-30 2012-12-25 The Board Of Trustees Of The Leland Stanford Junior University Derivation of neural stem cells from embryonic stem cells
DE102007036334A1 (de) * 2007-08-02 2009-02-05 Electrolux Home Products Corporation N.V. Basiseinheit zum induktiven Aufheizen und Induktionsflüssigkeitserhitzungssystem
US20100021437A1 (en) * 2008-04-07 2010-01-28 The McLean Hospital Corporation Whitehead Institute for Biomedical Research Neural stem cells derived from induced pluripotent stem cells
GB2460552B (en) * 2008-06-05 2011-09-07 Iti Scotland Ltd Stem cell culture media and methods
JP5734595B2 (ja) * 2010-08-03 2015-06-17 オリンパス株式会社 コロニーの特性評価方法
BR112013003031A2 (pt) * 2010-08-19 2016-06-14 Hoffmann La Roche método de produção de células hastes neurais (chn), células hastes neurais e seu uso, composição terapêutica e banco biológico de nscs
KR101226702B1 (ko) * 2010-10-08 2013-01-25 충북대학교 산학협력단 인간 콜린 아세틸트랜스퍼라아제를 발현하는 인간 신경줄기세포 및 이의 용도
TWI488641B (zh) * 2010-12-13 2015-06-21 生化學工業股份有限公司 椎間盤突出治療劑
KR20140121317A (ko) * 2013-04-06 2014-10-15 서울대학교산학협력단 비신경 세포로부터 유도 신경 줄기 세포의 생산 방법 및 이에 의하여 생산되는 유도 신경 줄기 세포
CN103305466B (zh) * 2013-06-09 2015-02-11 吉林省拓华生物科技有限公司 一种保持高细胞活率的神经干细胞的培养方法
ES2972541T3 (es) * 2014-09-08 2024-06-13 Riken Método para producir tejido progenitor cerebeloso
CN104673752A (zh) * 2015-03-14 2015-06-03 李�根 一种人脑干细胞库构建方法
WO2018107135A1 (en) * 2016-12-09 2018-06-14 Neoneuron Llc Method of treating neurological disorders with stem cell therapy
CN106924286A (zh) * 2017-02-16 2017-07-07 上海安集协康生物技术股份有限公司 一种经鼻腔给药用于帕金森病治疗的神经干细胞制剂
JP2024523361A (ja) 2021-06-17 2024-06-28 キュー－ステート バイオサイエンシーズ， インコーポレイテッド 神経細胞を生産するための方法
EP4355862A4 (en) * 2021-06-18 2025-08-06 Texas A & M Univ Sys METHODS OF PROCESSING ADULT NEURAL CELLS FROM MAMMALS AND THEIR DOSAGES

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5981165A (en) * 1991-07-08 1999-11-09 Neurospheres Holdings Ltd. In vitro induction of dopaminergic cells
CA2403000C (en) * 2000-03-14 2015-06-23 Es Cell International Pte Ltd Embryonic stem cells and neural progenitor cells derived therefrom
WO2004081172A2 (en) * 2003-03-12 2004-09-23 Reliance Life Sciences Pvt. Ltd. Derivation of terminally differentiated dopaminergic neurons from human embryonic stem cells

Non-Patent Citations (10)

* Cited by examiner, † Cited by third party
Title
Kawasaki,H.,er al..Induction of midbrain dopaminergic neurons from ES cells bystromal cell-derived inducing activity..Neuron28 1.2000,第31-33页左手栏，第35页-36页.
Kawasaki,H.,er al..Induction of midbrain dopaminergic neurons from ES cells bystromal cell-derived inducing activity..Neuron28 1.2000,第31-33页左手栏,第35页-36页. *
Pataky,DM,et al..Fibroblast growth factor treatment produces differential effects on survival and neurite outgrowth from identified bulbospinal neurons in vitro..Exp. Neurol.163 2.2000,357-372.
Pataky,DM,et al..Fibroblast growth factor treatment produces differential effects on survival and neurite outgrowth from identified bulbospinal neurons in vitro..Exp. Neurol.163 2.2000,357-372. *
Rousselet,A, et al..In vitro regulation of neuronal morphogenesis and polarity by astrocyte-derived factors..Dev. Biol.137 1.1990,33-45.
Rousselet,A, et al..In vitro regulation of neuronal morphogenesis and polarity by astrocyte-derived factors..Dev. Biol.137 1.1990,33-45. *
Yoshida,M.,et al..Neurotrophic effects of conditioned media of astrocytes isolated from different brain regions on hippocampal and cortical neurons..Experientia51 2.1995,133-136.
Yoshida,M.,et al..Neurotrophic effects of conditioned media of astrocytes isolated from different brain regions on hippocampal and cortical neurons..Experientia51 2.1995,133-136. *
Zhang,SC.,et al..In vitro differentiation of transplantable neural precursors from human embryonic stem cells..Nat. Biotechnol.19 12.2001,第1129-1132页.
Zhang,SC.,et al..In vitro differentiation of transplantable neural precursors from human embryonic stem cells..Nat. Biotechnol.19 12.2001,第1129-1132页. *

Also Published As

Publication number Publication date
IL165772A (en) 2012-05-31
TWI309678B (https=) 2009-05-11
CN1662645A (zh) 2005-08-31
AU2003246176A1 (en) 2004-02-02
JPWO2004007700A1 (ja) 2005-11-10
US8492145B2 (en) 2013-07-23
WO2004007700A1 (ja) 2004-01-22
US20050221479A1 (en) 2005-10-06
TW200411058A (en) 2004-07-01
CA2489206C (en) 2012-08-07
KR20050016636A (ko) 2005-02-21
JP4439396B2 (ja) 2010-03-24
HK1079812A1 (en) 2006-04-13
CA2489206A1 (en) 2004-01-22
EP1516926A4 (en) 2006-10-11
KR100846643B1 (ko) 2008-07-16
IL165772A0 (en) 2006-01-15
EP1516926A1 (en) 2005-03-23
AU2003246176B2 (en) 2006-09-07

Similar Documents

Publication Publication Date Title
CN1662645B (zh) 神经细胞的制备方法
JP6185907B2 (ja) 神経分化のための多能性幹細胞の予備刺激
JP2022078245A (ja) 多能性細胞を分化させるための方法
US20150147301A1 (en) Methods and compositions of producing patient-specific multipotent neuronal stem cells
JP2001526884A (ja) 神経前駆細胞、その製造方法および神経性欠陥治療におけるその使用
US20060121607A1 (en) Compositions and methods for neural differentiation of embryonic stem cells
CN103146649A (zh) 神经干细胞
WO2011041062A1 (en) Cranial neural crest stem cells and culture condition that supports their growth
US7763463B2 (en) Use of cyclic AMP and ascorbic acid to produce dopaminergic neurons from embryonic stem cells
US8628962B2 (en) Differentiation of stem cells into dopaminergic cells
CN101124319B (zh) 神经干细胞
AU704976B2 (en) Normal neural epithelial precursor cells
US20230399612A1 (en) Method for the generation of neurospheres
CN116478923B (zh) 一种星形胶质细胞的制备方法
CN120118844A (zh) 制备纯化的人神经前体细胞培养物的方法
EP1565549A1 (en) Method for the preparation, purification and differentiation of neurospheres from mammalian stem cells
HK40105534A (zh) 多巴胺能前体细胞及使用方法
HK1079812B (en) Process for producing nerve cells
Harness et al. Equivalence of Conventionally-Derived and Parthenote-Derived Human Embryonic
Slabá Neurogenetický potenciál kmenových buněk u myší
HK1075673B (en) Dopaminergic neurons and proliferation-competent precursor cells for treating parkinson's disease
HK1075673A1 (zh) 用於治療帕金森病的多巴胺能神經元和具有增殖能力的前體細胞

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1079812

Country of ref document: HK

ASS Succession or assignment of patent right

Owner name: TANABE MITSUBISHI PHARMACEUTICAL CO.

Free format text: FORMER OWNER: TANADE SEIYAKU CO., LTD.

Effective date: 20080516

C41 Transfer of patent application or patent right or utility model
TA01 Transfer of patent application right

Effective date of registration: 20080516

Address after: Japan Osaka City Plaza Osaka built town 3 chome 2 No. 10

Applicant after: MITSUBISHI TANABE PHARMA Corp.

Address before: Osaka City, Osaka of Japan

Applicant before: Tanabe Seiyaku Co.,Ltd.

C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication

Open date: 20050831

CI01 Publication of corrected invention patent application

Correction item: Rejection of patent application

Correct: Dismiss

False: Reject

Number: 32

Volume: 26

ERR Gazette correction

Free format text: CORRECT: PATENT APPLICATION REJECTION OF AFTER PUBLICATION; FROM: REJECTION TO: REVOCATION REJECTED

C14 Grant of patent or utility model
GR01 Patent grant
REG Reference to a national code

Ref country code: HK

Ref legal event code: GR

Ref document number: 1079812

Country of ref document: HK

CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20130612

Termination date: 20150623

EXPY Termination of patent right or utility model